Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Motor Imagery and Action Observation for Gait Function in MS

NCT07137624 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-01-03
Last updated
2026-09-18

Condition(s) studied

Multiple Sclerosis

Investigational drug(s) / intervention(s)

Action Observation + Motor ImageryNature Video

Action Observation + Motor Imagery: Participants will watch videos showing walking actions and will be instructed to mentally simulate the movement.

Nature Video: Participants will watch a video of nature scenes.

Study summary

This study will investigate whether mentally simulating walking movements while watching others walk can improve walking performance in individuals with Multiple Sclerosis (MS). Participants will be divided into two groups: one group will watch walking videos and imagine themselves walking, while the other group will watch nature scenes. The study will measure muscle activity and walking patterns to assess the effects. The results may help support the use of mental practice techniques to improve mobility in people with MS.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * A confirmed diagnosis of multiple sclerosis (MS) by a neurologist * No history of relapse within the past 3 months and not currently experiencing a relapse * A score of 24 or higher on the standardized Mini Mental State Examination Exclusion Criteria: * Presence of serious health conditions affecting the muscles, heart, lungs, or metabolism that could interfere with participation * History of other neurological disorders, head injury, or chronic psychiatric conditions * Chronic pain lasting longer than six months * Significant muscle stiffness in the legs that may affect EMG recordings * Hearing difficulties * Vision problems as determined by the Snellen visual acuity test

Primary outcome measure(s)

  • Change in Tibialis Anterior and Gastrocnemius Medialis Muscle Activity Amplitude — Before and immediately after the intervention
    Change in muscle activity amplitude (microvolts, µV) of tibialis anterior and gastrocnemius medialis during gait initiation measured by surface EMG.
  • Change in Tibialis Anterior and Gastrocnemius Medialis Muscle Activity Onset Latency — Before and immediately after the intervention.
    Change in onset latency (milliseconds, ms) of tibialis anterior and gastrocnemius medialis muscle activation during gait initiation measured by surface EMG.
  • Change in Step Length — Before and immediately after the intervention
    Change in step length (centimeters, cm) during gait initiation measured by the GAITRite system.
  • Change in Step Time — Before and immediately after the intervention
    Change in step time (seconds, s) during gait initiation measured by the GAITRite system.
  • Change in Step Width — Before and immediately after the intervention
    Change in step width (centimeters, cm) during gait initiation measured by the GAITRite system.
  • Change in Double Support Period — Before and immediately after the intervention
    Change in double support period (percentage of gait cycle, %) during gait initiation measured by the GAITRite system.
  • Change in Gait Velocity — Before and immediately after the intervention
    Change in gait velocity (centimeters per second, cm/s) during gait initiation measured by the GAITRite system.
  • Change in Cadence — Before and immediately after the intervention
    Change in cadence (steps per minute, steps/min) during gait initiation measured by the GAITRite system.

Trial sites (1)

FacilityCityRegionStatus
Hacettepe University, Faculty of Physical Therapy and Rehabilitation Ankara Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07137624 on ClinicalTrials.gov ↗ ← All trials in Turkey